Legal Opinion
Valeant Pharmaceuticals Intl. v. Mylan Pharmaceuticals Inc.
Court of Appeals for the Federal Circuit
Decided April 8, 2020No. 18-2097PublishedCited by 11 opinions
1Opinion of the Court
Case: 18-2097 Document: 89 Page: 1 Filed: 04/08/2020 United States Court of Appeals for the Federal Circuit ______________________ VALEANT PHARMACEUTICALS INTERNATIONAL, INC., SALIX PHARMACEUTICALS, INC., PROGENICS PHARMACEUTICALS, INC., WYETH LLC, FKA WYETH, Plaintiffs-Appellees v. MYLAN PHARMACEUTICALS INC., MYLAN INC., MYLAN LABORATORIES LIMITED, Defendants-Appellants ACTAVIS LLC, Defendant ______________________ 2018-2097 ______________________ Appeal from the United States District Court for the District of New Jersey in Nos. 2:15-cv-08180-SRC-CLW, 2:15-cv-08353-SRC-CLW,…
2Cases cited26 opinions
- Anderson v. Liberty Lobby, Inc.Supreme Court of the United States · 1986
- Celotex Corp. v. Catrett, Administratrix of the Estate of CatrettSupreme Court of the United States · 1986
- Graham v. John Deere Co. of Kansas CitySupreme Court of the United States · 1966
- KSR International Co. v. Teleflex Inc.Supreme Court of the United States · 2007
- Edward Seamans v. Temple UniversityCourt of Appeals for the Third Circuit · 2014
21 more not listed; retrieve them via the Exa API.
3Cited by11 opinions
- Astrazeneca Ab v. Mylan Pharmaceuticals Inc.Court of Appeals for the Federal Circuit · 2021
- Almirall, LLC v. Amneal Pharmaceuticals LLCCourt of Appeals for the Federal Circuit · 2022
- Teva Pharmaceuticals USA v. Corcept Therapeutics, Inc.Court of Appeals for the Federal Circuit · 2021
- Janssen Pharmaceuticals, Inc. v. Teva Pharmaceuticals USA, Inc.Court of Appeals for the Federal Circuit · 2025
- Almirall, LLC v. Amneal Pharmaceuticals LLCCourt of Appeals for the Federal Circuit · 2022
6 more not listed; retrieve them via the Exa API.